1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: June 14 – June 20, 2026
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: June 14 – June 20, 2026

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Kyle Diamantas, J.D., Acting Commissioner of Food and Drugs
No Significant Event

Official Name: Sean R. Keveney, J.D., Chief Counsel
Event Date: 06/16/2026
Location: Washington, DC
Subject: FDA Priorities
FDA Participant/Group: N/A
Non FDA Participant/Group: John Twomey (Tiber Creek Group);

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs
Event Date: 06/15/2026
Location: Philadelphia, PA
Subject: Drug Information Association (DIA) 2026 Global Annual Meeting; Panelist: How the Upcoming FDA User Fee Legislation Could Advance Innovation and Reshape the Agency
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Event Date: 06/15/2026
Location: Philadelphia, PA
Subject: Drug Information Association (DIA) 2026 Global Annual Meeting; Panelist: A Conversation About Quality: A Global Regulators Discussion
FDA Participant/Group: MARK ABDOO;
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives
Event Date: 06/15/2026
Location: Silver Spring, MD
Subject: Device Access Restriction Technology
FDA Participant/Group: BRIAN FAHEY; LUKE HALL;
Non FDA Participant/Group: Gianno Caldwell (Caldwell Strategic Consulting);

Event Date: 06/16/2026
Location: Washington, DC
Subject: Alliance for Regenerative Medicine Board of Directors Meeting
FDA Participant/Group: KRISTINE RAINE; KARIM MIKHAIL; LUKE HALL;
Non FDA Participant/Group: Alliance for Regenerative Medicine Board of Directors

Official Name: Donald A. Prater, D.V.M., Acting Deputy Commissioner for Food
Event Date: 06/15/2026
Location: Virtual
Subject: FDA Public Meeting - Challenges and Solutions in Lot-Level Food Traceability; Speaker: Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Event Date: 06/16/2026
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: ROBIN MCKINNON; KRISTI MULDOON JACOBS; RACHAEL SILKO;
Non FDA Participant/Group: Michael Werner, Parker Reynolds (Holland and Knight LLP); Giacomo Vitarelli, Phillip Fordham (Nutrinova);

Event Date: 06/18/2026
Location: College Park, MD
Subject: Dairy Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Michael Dykes, Roberta Wagner (International Dairy Foods Association);

Official Name: Melanie Keller, M.B.A., Deputy Commissioner for Operations and Chief Operating Officer
No Significant Event

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations
Event Date: 06/16/2026
Location: Silver Spring, MD
Subject: Ministry of Health and Family Welfare and the Central Drugs Standard Control Organization of India Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Akhilesh Singh, Anamika Mishra (Embassy of India); Harsh Mangla (Indian Ministry of Health and Family Welfare (MOHFW)); Rajeev Singh Raghuvanshi (Indian Central Drugs Standard Control Organization);

Official Name: Karim Mikhail, B.Pharm, MSc, Acting Director, Center for Biologics Evaluation and Research
No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health
No Significant Event

Official Name: Michael Davis, M.D., Ph.D., Acting Director, Center for Drug Evaluation and Research
Event Date: 06/15/2026
Location: Philadelphia, PA
Subject: Drug Information Association (DIA) 2026 Global Annual Meeting; Panelist: FDA Town Hall
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products
No Significant Event

Official Name: Timothy C. Schell, Ph.D., Director, Center for Veterinary Medicine
Event Date: 06/18/2026
Location: Austin, TX
Subject: Texas House Agriculture Committee Hearing on New World Screwworm
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other attendees

Back to Top